Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit

Robotic, Traditional Nipple-Conserving Mastectomies Have Similar Results

March 21st 2024, 1:00pm

Video

A new robot-assisted nipple-conserving mastectomy is “not very different” in terms of patient experiences versus the traditional procedure.

Addressing Side Effects of Metastatic Breast Cancer Treatment With Open Conversations

March 20th 2024, 9:00pm

Article

During the CURE Educated Patient® Breast Cancer Summit, an expert discussed her professional and personal experience with side effect management in metastatic breast cancer.

ctDNA Will Be ‘Part of a Precise Monitoring Program’ in Breast Cancer

March 19th 2024, 1:00pm

Article

ctDNA and CTC can lend information about early-stage breast cancer, but the best way to use this data is still being determined, an expert said at the CURE® Educated Patient® Breast Cancer Summit.

Differences Between Genetic, Genomic Testing in Breast Cancer

March 18th 2024, 9:00pm

Article

Recent recommendations — which were discussed at the CURE® Educated Patient® Breast Cancer Summit — addressed changes in both genetic and genomic testing in breast cancer.

Rethinking Physical and Mental Health Throughout the Breast Cancer Journey

March 17th 2024, 5:00pm

Article

A patient advocate and oncology nurse discuss the importance of physical and mental health during the breast cancer journey during a panel session at the CURE® Educated Patient® Breast Cancer Summit.

Why ‘All Patients’ With Breast Cancer Should Undergo Germline Testing

March 16th 2024, 5:00pm

Article

During the Miami Breast Cancer Conference and Educated Patient® Breast Cancer Summit, one expert stressed the importance of genetic testing for BRCA mutations.

How Beauty Techniques Help Patients Take ‘Your Power Back’

March 14th 2024, 3:00pm

Article

A patient with breast cancer shares skills she’s learned from the Look Good Feel Better program at the Miami Breast Cancer Conference and Educated Patient® Breast Cancer Summit.

Advancements, Unmet Needs in HR-Positive, HER2-Negative Breast Cancer

March 13th 2024, 7:00pm

Article

While CDK4/6 inhibitors are “liberating” for this breast cancer subset, questions remain about what to do in later lines of therapy, according to a presentation at the CURE® Educated Patient Breast Cancer Summit.

Genetic Testing for Breast Cancer May Benefit Family Members

March 12th 2024, 10:08pm

Article

An expert explained that patients with breast cancer who undergo genetic testing may help their family members, regardless of whether patients have children.

HER2 an ‘Actionable Biomarker’ in Breast Cancer Subset

March 12th 2024, 9:00pm

Article

At the Miami Breast Cancer Conference and Educated Patient Breast Cancer Summit, an expert explained HER2-positive breast cancer and gave an overview of effective treatment options in this space.